Literature DB >> 12482860

Crystal structure of human protein-tyrosine phosphatase SHP-1.

Jian Yang1, Lijun Liu, Dandan He, Xi Song, Xiaoshan Liang, Zhizhuang Joe Zhao, G Wayne Zhou.   

Abstract

SHP-1 is a cytosolic protein-tyrosine phosphatase that behaves as a negative regulator in eukaryotic cellular signaling pathways. To understand its regulatory mechanism, we have determined the crystal structure of the C-terminal truncated human SHP-1 in the inactive conformation at 2.8-A resolution and refined the structure to a crystallographic R-factor of 24.0%. The three-dimensional structure shows that the ligand-free SHP-1 has an auto-inhibited conformation. Its N-SH2 domain blocks the catalytic domain and keeps the enzyme in the inactive conformation, which supports that the phosphatase activity of SHP-1 is primarily regulated by the N-SH2 domain. In addition, the C-SH2 domain of SHP-1 has a different orientation from and is more flexible than that of SHP-2, which enables us to propose an enzymatic activation mechanism in which the C-SH2 domains of SHPs could be involved in searching for phosphotyrosine activators.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12482860     DOI: 10.1074/jbc.M210430200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

Review 1.  Immune regulation by phospholipase C-β isoforms.

Authors:  Wenbin Xiao; Yuko Kawakami; Toshiaki Kawakami
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

2.  Mechanism of phosphorylation-induced activation of phospholipase C-gamma isozymes.

Authors:  Aurelie Gresset; Stephanie N Hicks; T Kendall Harden; John Sondek
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

3.  A tandem SH2 domain in transcription elongation factor Spt6 binds the phosphorylated RNA polymerase II C-terminal repeat domain (CTD).

Authors:  Mai Sun; Laurent Larivière; Stefan Dengl; Andreas Mayer; Patrick Cramer
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

4.  Antagonism or synergism. Role of tyrosine phosphatases SHP-1 and SHP-2 in growth factor signaling.

Authors:  Ning Wang; Zhe Li; Ronghua Ding; Gerald D Frank; Takaaki Senbonmatsu; Erwin J Landon; Tadashi Inagami; Zhizhuang Joe Zhao
Journal:  J Biol Chem       Date:  2006-06-08       Impact factor: 5.157

5.  Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger.

Authors:  Ben A Croker; Brian R Lawson; Sophie Rutschmann; Michael Berger; Celine Eidenschenk; Amanda L Blasius; Eva Marie Y Moresco; Sosathya Sovath; Louise Cengia; Leonard D Shultz; Argyrios N Theofilopoulos; Sven Pettersson; Bruce Alan Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-19       Impact factor: 11.205

Review 6.  Shp1 function in myeloid cells.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  J Leukoc Biol       Date:  2017-06-12       Impact factor: 4.962

7.  A missense methionine mutation augments catalytic activity but reduces thermal stability in two protein tyrosine phosphatases.

Authors:  Anthony C Bishop
Journal:  Biochem Biophys Res Commun       Date:  2016-11-02       Impact factor: 3.575

8.  Rapid T cell receptor-mediated SHP-1 S591 phosphorylation regulates SHP-1 cellular localization and phosphatase activity.

Authors:  Yin Liu; Michael J Kruhlak; Jian-Jiang Hao; Stephen Shaw
Journal:  J Leukoc Biol       Date:  2007-06-15       Impact factor: 4.962

9.  Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein-Barr virus.

Authors:  Priya Saju; Naoko Murata-Kamiya; Takeru Hayashi; Yoshie Senda; Lisa Nagase; Saori Noda; Keisuke Matsusaka; Sayaka Funata; Akiko Kunita; Masayuki Urabe; Yasuyuki Seto; Masashi Fukayama; Atsushi Kaneda; Masanori Hatakeyama
Journal:  Nat Microbiol       Date:  2016-03-14       Impact factor: 17.745

10.  Role of tyrosine phosphatase SHP-1 in the mechanism of endorepellin angiostatic activity.

Authors:  Alexander Nyström; Zabeena P Shaik; Donald Gullberg; Thomas Krieg; Beate Eckes; Roy Zent; Ambra Pozzi; Renato V Iozzo
Journal:  Blood       Date:  2009-09-29       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.